Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 834027, 11 pages
http://dx.doi.org/10.1155/2013/834027
Research Article

Oral Administration of Alkylglycerols Differentially Modulates High-Fat Diet-Induced Obesity and Insulin Resistance in Mice

1Xinhua Hospital, Shanghai Institute for Pediatric Research, Shanghai Jiao Tong University, School of Medicine, Shanghai 200092, China
2Department of Immunology, Nanjing Medical University, Nanjing 210029, China
3Fudan Children’s Hospital, Fudan University, School of Medicine, Shanghai 201102, China
4Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Shanghai 200092, China

Received 1 January 2013; Accepted 5 June 2013

Academic Editor: Wei Jia

Copyright © 2013 Mingshun Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Tilg and A. R. Moschen, “Adipocytokines: mediators linking adipose tissue, inflammation and immunity,” Nature Reviews Immunology, vol. 6, no. 10, pp. 772–783, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Xu, G. T. Barnes, Q. Yang et al., “Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1821–1830, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Wu, S. Ghosh, X. D. Perrard et al., “T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity,” Circulation, vol. 115, no. 8, pp. 1029–1038, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. G. S. Hotamisligil, “Inflammation and metabolic disorders,” Nature, vol. 444, no. 7121, pp. 860–867, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. C. G. Bordier, N. Sellier, A. P. Foucault, and F. le Goffic, “Purification and characterization of deep sea shark Centrophorus squamosus liver oil 1-O-alkylglycerol ether lipids,” Lipids, vol. 31, no. 5, pp. 521–528, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Iannitti and B. Palmieri, “An update on the therapeutic role of alkylglycerols,” Marine Drugs, vol. 8, no. 8, pp. 2267–2300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Brohult, J. Brohult, and S. Brohult, “Biochemical effects of alkoxyglycerols and their use in cancer therapy,” Acta chemica Scandinavica, vol. 24, no. 2, p. 730, 1970. View at Google Scholar · View at Scopus
  8. B. Hallgren, A. Niklasson, G. Ställberg, and H. Thorin, “On the occurrence of 1-O-alkylglycerols and 1-O-(2-methoxyalkyl)glycerols in human colostrum, human milk, cow's milk, sheep's milk, human red bone marrow, red cells, blood plasma and a uterine carcinoma,” Acta chemica Scandinavica B, vol. 28, no. 9, pp. 1029–1034, 1974. View at Google Scholar · View at Scopus
  9. D. G. Osmond, P. J. Roylance, A. J. Webb, and J. M. Yoffey, “The action of batyl alcohol and selachyl alcohol on the bone marrow of the guinea pig,” Acta haematologica, vol. 29, pp. 180–186, 1963. View at Google Scholar · View at Scopus
  10. P. Langen, H. Brachwitz, and J. Schildt, “Inhibition of proliferation of Ehrlich ascites carcinoma cells in vitro and in vivo by halogeno analogues of long chain acyl- and alkylglycerols,” Acta Biologica et Medica Germanica, vol. 38, no. 7, pp. 965–974, 1979. View at Google Scholar · View at Scopus
  11. F. Pédrono, B. Martin, C. Leduc et al., “Natural alkylglycerols restrain growth and metastasis of grafted tumors in mice,” Nutrition and Cancer, vol. 48, no. 1, pp. 64–69, 2004. View at Google Scholar · View at Scopus
  12. E. Skopińska-Rózewska, J. Chorostowska-Wynimko, M. Krotkiewski et al., “Inhibitory effect of Greenland shark liver oil combined with squalen and arctic birch ashes on angiogenesis and L-1 sarcoma growth in Balb/c mice,” Polish Journal of Veterinary Sciences, vol. 6, supplement 3, pp. 54–56, 2003. View at Google Scholar · View at Scopus
  13. M.-S. Zeng, X. Li, Y. Liu et al., “A high-selenium diet induces insulin resistance in gestating rats and their offspring,” Free Radical Biology and Medicine, vol. 52, no. 8, pp. 1335–1342, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. W. E. Berdel, W. R. Bausert, and H. U. Weltzien, “The influence of alkyl-lysophospholipids and lysophospholipid-activated macrophages on the development of metastasis of 3-Lewis lung carcinoma,” European Journal of Cancer and Clinical Oncology, vol. 16, no. 9, pp. 1199–1204, 1980. View at Google Scholar · View at Scopus
  15. E. Ortega Martinez de Victoria, X. Xu, J. Koska et al., “Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy pima Indians,” Diabetes, vol. 58, no. 2, pp. 385–393, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Xie, D. Gu, J. Li, K. Cui, and Y. Zhang, “Effects and action mechanisms of berberine and rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice,” PLoS One, vol. 6, no. 9, Article ID e24520, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Vijay-Kumar, S. M. Vanegas, N. Patel, J. D. Aitken, T. R. Ziegler, and V. Ganji, “Fish oil rich diet in comparison to saturated fat rich diet offered protection against lipopolysaccharide-induced inflammation and insulin resistance in mice,” Nutrition and Metabolism, vol. 8, no. 1, article 16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Masaki, T. Kurisaki, K. Shirakawa, and A. Sehara-Fujisawa, “Role of meltrin α (ADAM12) in obesity induced by high-fat diet,” Endocrinology, vol. 146, no. 4, pp. 1752–1763, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Hwang, B. C. Jang, G. Yu, and M. Boudreau, “Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: mediation through both mitogen-activated protein kinase and NF-κB signaling pathways in macrophages,” Biochemical Pharmacology, vol. 54, no. 1, pp. 87–96, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. M. J. Holness, G. K. Greenwood, N. D. Smith, and M. C. Sugden, “PPARα activation and increased dietary lipid oppose thyroid hormone signaling and rescue impaired glucose-stimulated insulin secretion in hyperthyroidism,” American Journal of Physiology—Endocrinology and Metabolism, vol. 295, no. 6, pp. E1380–E1389, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Brohult, J. Brohult, S. Brohult, and I. Joelsson, “Effect of alkoxyglycerols on the frequency of fistulas following radiation therapy for carcinoma of the uterine cervix,” Acta Obstetricia et Gynecologica Scandinavica, vol. 58, no. 2, pp. 203–207, 1979. View at Google Scholar · View at Scopus
  22. S. Homma, I. Millman, and N. Yamamoto, “A serum factor for macrophage activation after in vitro dodecylglycerol treatment of mouse lymphocytes,” Immunology and Cell Biology, vol. 68, part 2, pp. 137–142, 1990. View at Google Scholar · View at Scopus
  23. S. Y. Oh and L. S. Jadhav, “Effects of dietary alkylglycerols in lactating rats on immune responses in pups,” Pediatric Research, vol. 36, no. 3, pp. 300–305, 1994. View at Google Scholar · View at Scopus
  24. A. Anadón, M. A. Martínez, I. Ares et al., “Acute and repeated dose (28 days) oral safety studies of an alkoxyglycerol extract from shark liver oil in rats,” Journal of Agricultural and Food Chemistry, vol. 58, no. 3, pp. 2040–2046, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Lewkowicz, M. Banasik, E. Głowacka, N. Lewkowicz, and H. Tchórzewski, “Effect of high doses of shark liver oil supplementation on T cell polarization and peripheral blood polymorphonuclear cell function,” Polski Merkuriusz Lekarski, vol. 18, no. 108, pp. 686–692, 2005. View at Google Scholar · View at Scopus
  26. R. Ziegler, W. Jobst, H. Minne, and J. D. Faulhaber, “Calciotropic hormones and lipolysis of human adipose tissue: role of extracellular calcium as conditioning but not regulating factor,” Endokrinologie, vol. 75, no. 1, pp. 77–88, 1980. View at Google Scholar · View at Scopus
  27. M. E. Rausch, S. Weisberg, P. Vardhana, and D. V. Tortoriello, “Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration,” International Journal of Obesity, vol. 32, no. 3, pp. 451–463, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Jager, T. Grémeaux, M. Cormont, Y. le Marchand-Brustel, and J.-F. Tanti, “Interleukin-1β-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression,” Endocrinology, vol. 148, no. 1, pp. 241–251, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. G. S. Hotamisligil, D. L. Murray, L. N. Choy, and B. M. Spiegelman, “Tumor necrosis factor α inhibits signaling from the insulin receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 11, pp. 4854–4858, 1994. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Gäbele, K. Dostert, C. Dorn, E. Patsenker, F. Stickel, and C. Hellerbrand, “A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis,” Alcoholism, vol. 35, no. 7, pp. 1361–1367, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Beutler, “Inferences, questions and possibilities in Toll-like receptor signalling,” Nature, vol. 430, no. 6996, pp. 257–263, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Akira, “Toll-like receptors and innate immunity,” Advances in Immunology, vol. 78, pp. 1–56, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Faure, L. Thomas, H. Xu, A. E. Medvedev, O. Equils, and M. Arditi, “Bacterial lipopolysaccharide and IFN-γ induce toll-like receptor 2 and toll-like receptor 4 expression in human endothelial cells: role of NF-κB activation,” Journal of Immunology, vol. 166, no. 3, pp. 2018–2024, 2001. View at Google Scholar · View at Scopus
  34. M. J. Song, K. H. Kim, J. M. Yoon, and J. B. Kim, “Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes,” Biochemical and Biophysical Research Communications, vol. 346, no. 3, pp. 739–745, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Hwang, “Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through Toll-like receptor 4-derived signaling pathways,” The FASEB Journal, vol. 15, no. 14, pp. 2556–2564, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Y. Lee, K. H. Sohn, S. H. Rhee, and D. Hwang, “Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4,” Journal of Biological Chemistry, vol. 276, no. 20, pp. 16683–16689, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Y. Lee, A. Plakidas, W. H. Lee et al., “Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids,” Journal of Lipid Research, vol. 44, no. 3, pp. 479–486, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. S. A. Lee, H. J. Kim, K. C. Chang et al., “DHA and EPA down-regulate COX-2 expression through suppression of NF-κB activity in LPS-treated human umbilical vein endothelial cells,” Korean Journal of Physiology and Pharmacology, vol. 13, no. 4, pp. 301–307, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Ocaña, C. Gómez-Asensio, E. Arranz-Gutiérrez, C. Torres, F. J. Señoráns, and G. Reglero, “In vitro study of the effect of diesterified alkoxyglycerols with conjugated linoleic acid on adipocyte inflammatory mediators,” Lipids in Health and Disease, vol. 9, article 36, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. A.-L. Deniau, P. Mosset, F. Pédrono, R. Mitre, D. le Bot, and A. B. Legrand, “Multiple beneficial health effects of natural alkylglycerols from shark liver oil,” Marine Drugs, vol. 8, no. 7, pp. 2175–2184, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. N. W. Chang and P. C. Huang, “Effects of the ratio of polyunsaturated and monounsaturated fatty acid to saturated fatty acid on rat plasma and liver lipid concentrations,” Lipids, vol. 33, no. 5, pp. 481–487, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. S. Diniz, A. C. Cicogna, C. R. Padovani, L. S. Santana, L. A. Faine, and E. L. B. Novelli, “Diets rich in saturated and polyunsaturated fatty acids: metabolic shifting and cardiac health,” Nutrition, vol. 20, no. 2, pp. 230–234, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. F.-H. Liao, T.-H. Liou, W.-C. Chiu, M.-J. Shieh, and Y.-W. Chien, “Differential effects of high MUFA with high or low P/S ratio (polyunsaturated to saturated fatty acids) on improving hepatic lipolytic enzymes and mediating PPARγ related with lipoprotein lipase and hormone-sensitive lipase of white adipose tissue in diet-induced obese hamster,” International Journal of Obesity, vol. 34, no. 11, pp. 1608–1617, 2010. View at Google Scholar
  44. F. B. Hu, J. E. Manson, and W. C. Willett, “Types of dietary fat and risk of coronary heart disease: a critical review,” Journal of the American College of Nutrition, vol. 20, no. 1, pp. 5–19, 2001. View at Google Scholar · View at Scopus
  45. J. Salmerón, F. B. Hu, J. E. Manson et al., “Dietary fat intake and risk of type 2 diabetes in women,” American Journal of Clinical Nutrition, vol. 73, no. 6, pp. 1019–1026, 2001. View at Google Scholar · View at Scopus
  46. A. V. Pogozheva, S. A. Derbeneva, N. V. Anykina et al., “The clinical and experimental research of metabolic effects of shark liver oil,” Voprosy Pitaniia, vol. 76, no. 6, pp. 28–32, 2007. View at Google Scholar · View at Scopus
  47. C. McCrory and R. Layte, “Breastfeeding and risk of overweight and obesity at nine-years of age,” Social Science and Medicine, vol. 75, no. 2, pp. 323–330, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Mori, H. Kondo, T. Hase, I. Tokimitsu, and T. Murase, “Dietary fish oil upregulates intestinal lipid metabolism and reduces body weight gain in C57BL/6J mice,” Journal of Nutrition, vol. 137, no. 12, pp. 2629–2634, 2007. View at Google Scholar · View at Scopus
  49. F. Belzung, T. Raclot, and R. Groscolas, “Fish oil n-3 fatty acids selectively limit the hypertrophy of abdominal fat depots in growing rats fed high-fat diets,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 264, no. 6, part 2, pp. R1111–R1118, 1993. View at Google Scholar · View at Scopus
  50. Z. Zhang, W. K. Yeung, Y. Huang, and Z.-Y. Chen, “Effect of squalene and shark liver oil on serum cholesterol level in hamsters,” International Journal of Food Sciences and Nutrition, vol. 53, no. 5, pp. 411–418, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Kilincalp, M. Deveci, O. Basar, F. Ekiz, S. Coban, and O. Yuksel, “Shark liver oil: hidden dangers,” Annals of Hepatology, vol. 11, no. 5, pp. 728–730.